diffusion weighted imaging
Recently Published Documents


TOTAL DOCUMENTS

3690
(FIVE YEARS 967)

H-INDEX

100
(FIVE YEARS 10)

2022 ◽  
Author(s):  
Weimin Liu ◽  
Simin Chen ◽  
Jianning Chen ◽  
Ting Jiang ◽  
Li Quan ◽  
...  

Intrahepatic splenosis is quite rare and is often misdiagnosed as other lesions. We present two cases of intrahepatic splenosis examined with hepatobiliary contrast agents, intravoxel incoherent motion diffusion-weighted imaging and magnetic resonance elastography. We discuss various imaging modalities and the roles of various magnetic resonance imaging methods in diagnosis. We also discuss the differentiating features that allow the correct diagnosis to be made and provide a brief review of the literature.


2022 ◽  
Vol 4 (1) ◽  
Author(s):  
Debosmita Biswas ◽  
Daniel S. Hippe ◽  
Yi Wang ◽  
Michaela R. DelPriore ◽  
Mladen Zečević ◽  
...  

Radiation ◽  
2021 ◽  
Vol 2 (1) ◽  
pp. 52-61
Author(s):  
Francesco Sanvito ◽  
Anna Gallotti ◽  
Lorenzo Cobianchi ◽  
Alessandro Vanoli ◽  
Nicholas S. Cho ◽  
...  

Rokitansky-Aschoff sinuses (RAS) are a common imaging finding in gallbladder adenomyomatosis (ADM), often presenting as fundal cystic spaces. Intracholecystic papillary neoplasm (ICPN) is a relatively uncommon pre-invasive tumor of the gallbladder epithelium that rarely involves RAS mucosa. We compare two cases that showed similar fundal cystic spaces resembling RAS, in which Magnetic Resonance Diffusion-Weighted Imaging (MR-DWI) was valuable for detecting (or ruling out) an underlying malignant ICPN. Evidence from the literature overall supports the role of MR-DWI for detecting intracholecystic malignant tissue.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Danping Huang ◽  
Ruimeng Yang ◽  
Yong Zou ◽  
Hongmei Lin ◽  
Xiangdong Xu ◽  
...  

Objective. To investigate the treatment effect of a vascular-disrupting agent, M410, using diffusion-weighted imaging in a rabbit model of hepatic VX2 tumor. Methods. 28 New Zealand white rabbit models with VX2 liver tumors were established and were randomly divided into M410 (intravenous injection of M410 at a dose of 25 mg/kg every three days) and control (intravenous injection of saline every three days) groups. Conventional and diffusion-weighted imaging (DWI) were acquired on a 3.0 T MR unit at baseline, 4 h, d 1, d 4, d 7, and d 14 posttreatment. B-value with 700 (s/mm2) was chosen during DWI examinations. Tumor volume and apparent diffusion coefficient (ADC) values of the entire tumor and solid component of the tumor at every time point were measured. Two randomly chosen rabbits from each group were sacrificed for H&E staining and CD34 immunohistochemical assessments at each time point. An independent sample t-test was used to assess differences in tumor sizes and ADC values of the entire tumor and solid component of tumors between two groups, with P < 0.05 considered statistically significant. Result. There was no significant difference in tumor volume between the two groups at baseline, 4 h, and d 1. With time, the tumors in the control group grew significantly faster than those in the M410 group, and the average ADC values of the M410 group were lower than those of the control group at d 1 and higher than those of the control group at d 4; as such, there were statistical differences between the two groups at these two time points but not at the other four time points. The following pathological results reflected the underlying morphological changes and vascular alterations. Conclusions. M410 performed well in inhibiting the growth of the hepatic VX2 tumor which could be noninvasively monitored by DWI metrics.


Sign in / Sign up

Export Citation Format

Share Document